All-Island HBAN Director John Phelan joined Newstalk Business Breakfast Monday June 22nd to discuss how HBAN has adapted to continue pitching throughout COVID-19. He also offered important insights and advice for Irish start-ups and discussed HBAN's plans for the future.
The Boatyard Distillery said today that it has successfully closed a £634,000 investment round through the Halo Business Angel Network (HBAN) from private investors and Co-Fund II. It also announced that it has started producing a new range of hand sanitiser in response to the coronavirus pandemic.
Life science software company Overwatch has closed a significant funding round that will accelerate product development and enable the company to grow its existing customer portfolio across both Europe and the USA.
HBAN will host its annual All-Island Conference at Powerscourt Hotel, Wicklow, on Thursday, 6th February 2020. The all-day event aims to encourage more people to get involved in business angel investing, highlighting the opportunities and rewards that it presents.
HBAN, the all-island organisation responsible for the promotion of business angel investment and a joint initiative between Enterprise Ireland, InterTradeIreland and Invest Northern Ireland, today announces that its winning streak at the European Business Angels Network (EBAN) annual congress has continued. Phorest, the HBAN-backed salon software company, was named most successful business financed by early stage investors at this year’s event in Helsinki.
Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, today announced the company has secured €3.6 million ($4 million) through two grant funding awards. The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Funds from these grants will support regulatory and clinical programs leading to the commercialization of the company’s BioHealxTM device, which is designed to treat anal fistula, a painful colorectal condition that affects one in 5,000 people worldwide.
If you‘re a high potential Start Up that has a new innovative product or service ready for commercialisation and/or have achieved some early traction and are raising finance to scale internationally please contact us.